Healthcare · Healthcare Services
QVM read Quality, pricey and fading Quality Strong, Valuation Expensive, Momentum Bearish
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Metropolis Healthcare, also known as Metropolis Labs, is an Indian multinational chain of diagnostic labs, with its central laboratory in Mumbai, Maharashtra. Metropolis Healthcare has a chain of 124 clinical laboratories and 2400 collection centers across 7 countries including India. The healthcare company was founded in 1980. The company went public in April 2019.
Source: Wikipedia
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #15 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 2 Jun 2025 | Sushil Shah Family Trust | Promoter | Buy | 0 | ₹0 |
| 2 Jun 2025 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 28 Mar 2025 | Duru Shah Family Trust | Promoter group | Buy | 0 | ₹0 |
| 28 Mar 2025 | Dr. Duru Sushil Shah | Promoter group | Sell | 0 | ₹0 |
| 22 Aug 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 22 Aug 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 20 Aug 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 20 Aug 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 7 Jun 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| 7 Jun 2024 | Sushil Kanubhai Shah | Promoter | Sell | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 11 Aug 2026 | MORGAN STANLEY ASIA SINGAPORE PTE | Block | Buy | 525,500 | 564.0000 | NSE |
| 11 Aug 2026 | METZ ADVISORY LLP | Block | Sell | 1,050,000 | 564.0000 | NSE |
| 11 Aug 2026 | ICICI PRUDENTIAL MUTUAL FUND | Block | Buy | 525,500 | 564.0000 | NSE |
| 11 Aug 2026 | DURU SHAH FAMILY TRUST | Block | Sell | 1,050,000 | 564.0000 | NSE |
| 11 Aug 2026 | ADITYA BIRLA SUN LIFE MUTUAL FUND | Block | Buy | 1,049,000 | 564.0000 | NSE |
| 11 Aug 2026 | METZ ADVISORY LLP | Bulk | Sell | 1,050,000 | 564.0000 | NSE |
| 11 Aug 2026 | DURU SHAH FAMILY TRUST | Bulk | Sell | 1,050,000 | 564.0000 | NSE |
| 11 Aug 2026 | ADITYA BIRLA SUN LIFE MUTUAL FUND | Bulk | Buy | 1,049,000 | 564.0000 | NSE |
| 4 Dec 2025 | CORE DIAGNOSTICS (MAURITIUS) PRIVATE LIMITED | Bulk | Sell | 292,457 | 1905.1100 | BSE |
| 16 Oct 2025 | GOLDMAN SACHS BANK EUROPESE - ODI | Block | Buy | 55,000 | 1944.0000 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 19 May 2026 | Interim Dividend - Re 1 Per Share | 1.0000 | 19 May 2026 |
| 11 Nov 2025 | Interim Dividend - Rs 4 Per Share | 4.0000 | 11 Nov 2025 |
| 17 Nov 2023 | Interim Dividend - Rs 4 Per Share | 4.0000 | 17 Nov 2023 |
| 23 Feb 2023 | Interim Dividend - Rs 8 Per Share | 8.0000 | 23 Feb 2023 |
| 21 Feb 2022 | Interim Dividend - Rs. 8 Per Share | 8.0000 | 22 Feb 2022 |
| 17 Feb 2021 | Interim Dividend - Rs 8 Per Share | 8.0000 | 19 Feb 2021 |
| 13 Feb 2020 | Interim Dividend - Rs 8 Per Share | 8.0000 | 15 Feb 2020 |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 20 Mar 2026 | BONUS | Bonus 3:1 |
| 10 Aug 2023 | OTHER | Annual General Meeting |
| 8 Aug 2022 | OTHER | Annual General Meeting |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 4 Aug 2026 | Financial Results | Yes |
| 13 May 2026 | Financial Results/Dividend | Yes |
| 4 Feb 2026 | Bonus | — |
| 4 Feb 2026 | Financial Results | Yes |
| 4 Nov 2025 | Financial Results/Dividend | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Single-stock futures available for this stock -- OI buildup, PCR, Max Pain and Greeks are all on the full F&O page.
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
